BDR-762

N/A

Report date: 2023/10/27 18:05:25

Base Information

Drug NameBDR-762
Drug Alias NameBDR-762RY-107
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionProteins replacementsGene transference
TargetsProteins
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMDimune IncReyon Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMDimune Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A